How Does Platelet Help Reactivate Dormant Hair Follicles in Men and Women with Thinning Hair?

Hair thinning is not only a cosmetic issue but also a biological process that reflects cellular aging, hormonal imbalance, and microvascular deterioration. In recent years, Platelet-Rich Plasma (PRP) has emerged as a possible tool to awaken dormant hair follicles in both men and women. However, understanding how this process occurs—and how well it actually works—requires examining the available scientific evidence critically rather than accepting clinical promises at face value.

Platelets: Microscopic Agents of Repair

Platelets are small, anucleate cell fragments circulating in the bloodstream, primarily known for their role in hemostasis (blood clotting). Beyond this, they contain hundreds of bioactive molecules stored in their alpha granules, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor 1 (IGF-1). When released, these molecules initiate and regulate processes such as angiogenesis (formation of new blood vessels), fibroblast activation, and tissue remodeling.

In the scalp, these same mechanisms may influence hair follicle biology. Hair follicles alternate between three phases: the anagen phase (growth), catagen phase (transition), and telogen phase (rest). In individuals with androgenetic alopecia or other forms of hair thinning, a large number of follicles remain trapped in the telogen phase. The biological rationale for PRP is that its growth factors can signal these follicles to re-enter the anagen phase by enhancing oxygenation, nutrient diffusion, and dermal papilla cell metabolism.

PRP: The Autologous Growth Factor Reservoir

Platelet-Rich Plasma is derived from a patient’s own blood through centrifugation, which separates plasma enriched with platelets from red and white blood cells. This plasma is then re-injected into the scalp. The concentration of platelets is typically three to five times higher than in normal blood. Upon injection, platelets are activated—either mechanically by the needle or chemically using calcium chloride—releasing their stored growth factors in a controlled manner.

The treatment aims to create a microenvironment of regeneration, stimulating hair follicle stem cells and dermal papilla cells, two populations essential for hair formation and cycling. Through these interactions, PRP may theoretically induce angiogenesis and extracellular matrix remodeling, two conditions necessary for dormant follicles to resume growth. However, it is important to emphasize that while this biological mechanism is plausible, results vary widely depending on the preparation method, patient profile, and injection technique.

What the Research Actually Shows

A frequently cited study by Gentile et al. (2015) conducted in Rome, Italy, provides early evidence supporting PRP. The authors performed a randomized, placebo-controlled, half-head trial involving 23 male participants with androgenetic alopecia. Over a period of three months, patients received three PRP injections on one side of the scalp and saline on the other. Hair density and thickness were evaluated through phototrichograms and global photography.

Results indicated a mean increase of 33.6 hairs per cm² on the PRP-treated side compared to baseline. Despite its encouraging findings, the study’s small sample size and short duration limit its generalizability and fail to demonstrate long-term efficacy (Gentile et al., 2015).

In a more recent investigation, Mapar et al. (2021) performed a double-blind, split-scalp study on 40 women diagnosed with female pattern hair loss. Participants received either PRP or saline injections over six months, with results evaluated by dermoscopic imaging and trichoscopy. The researchers observed a statistically significant increase in both hair count and shaft diameter in the PRP-treated regions. However, the absence of comparison with standard treatments such as topical minoxidil makes it difficult to determine whether PRP’s efficacy is superior or merely additive (Mapar et al., 2021).

A broader overview was offered by Gupta et al. (2022) in a systematic review and meta-analysis of 15 randomized controlled trials comprising more than 400 participants. The analysis found that PRP produced measurable improvements in hair density compared to placebo, though heterogeneity among studies was substantial. Variations in platelet concentration, activation methods, and injection frequency made the data difficult to unify. Consequently, the authors emphasized that PRP remains an experimental therapy until standardized clinical protocols are established (Gupta et al., 2022).

What Happens at the Cellular Level?

Once injected, PRP interacts with the dermal papilla, the specialized cluster of mesenchymal cells located at the follicle base. These cells orchestrate the transition between hair growth phases by regulating epithelial stem cell activity. PRP-derived growth factors such as IGF-1 and EGF bind to cellular receptors, activating intracellular signaling pathways that promote cell proliferation and angiogenesis. Increased expression of Ki-67, a protein marker of cell division, has been documented in scalp biopsies following PRP treatment, suggesting that follicular cells become metabolically active.

Moreover, PRP’s anti-inflammatory cytokines may reduce oxidative stress, a biochemical state that damages DNA and impairs hair follicle function. This restorative effect on the follicular microenvironment may explain why some patients experience a return of vellus (fine) hairs and gradual thickening of existing strands. Nonetheless, these effects are not guaranteed, and a considerable number of patients report minimal or no improvement.

Evaluating Limitations and Safety

Despite the promise, several limitations persist. Most studies have short follow-up periods—typically three to six months—and rarely assess outcomes beyond one year. PRP preparation methods differ significantly between clinics, with no consensus on the ideal platelet concentration or activation technique. In addition, patient variability—including hormonal status, nutrition, and degree of follicle miniaturization—affects outcomes.

According to a 2023 report from the World Health Organization (WHO) and the National Institutes of Health (NIH), PRP remains categorized as a regenerative therapy under clinical investigation. The U.S. Food and Drug Administration (FDA) currently regulates PRP devices as medical instruments rather than approved treatments for hair loss.

Thus, clinicians should inform patients that PRP’s use in this context is considered off-label, and long-term safety data are limited. While adverse effects are generally mild (such as local redness or swelling), repeated injections over time require more rigorous evaluation to rule out potential fibrosis or microvascular damage.

The Critical Takeaway

**PRP does not replace established treatments like minoxidil or finasteride, nor does it guarantee follicular reactivation for everyone. **However, it provides an intriguing biological approach that uses the body’s own regenerative signals to attempt to awaken dormant follicles. For patients considering this procedure, it is crucial to understand that its success depends on multiple variables and that the evidence, though growing, is not yet definitive. The science behind platelet-based regeneration is strong in theory but still evolving in clinical application.

---

References

Gentile, P., Garcovich, S., Bielli, A., Scioli, M. G., Orlandi, A., & Cervelli, V. (2015). The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial. Stem Cells Translational Medicine, 4(11), 1317–1323. https://pubmed.ncbi.nlm.nih.gov/26015757/

Mapar, M., Pakravan, A., Hosseini, S. H., & Moeineddin, F. (2021). Efficacy of Platelet-Rich Plasma in Female Pattern Hair Loss: A Split-Scalp Study. Dermatologic Therapy, 34(3), e14962. https://pubmed.ncbi.nlm.nih.gov/33783555/

Gupta, A. K., Carviel, J. L., & Abramovits, W. (2022). Platelet-Rich Plasma for Hair Loss: A Systematic Review and Meta-Analysis. Journal of Cutaneous Medicine and Surgery, 26(5), 495–508. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245138/